Nurse Practitioner, Family · Statesboro, GA
NPI
1417274358
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
204 S Main St
Statesboro, GA, 30458
Phone (912) 662-6501
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,654
62 services
Medicare patients, 2024
26
Average age 59
Drug cost, 2024
$2.1M
1,119 prescriptions
Company payments, 2025
$32.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gina Winnette was code 99214 (office e&m - established), 33 times for 26 patients. In total Gina Winnette billed 62 services in 8 codes, and Medicare paid $2,654.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 33 | 26 | $63.85 | $2,107 |
| 36415 Venipuncture Blood Collection | Office | 23 | 19 | $3.92 | $90.16 |
By year: 2022 $2,787 for 70 services; 2023 $3,350 for 87 services; 2024 $2,654 for 62 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 19 | $3.92 | $90.16 |
Medicare prescription drug claims, 2024
In 2024, the drug Gina Winnette prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 207 prescriptions and refills. In total Gina Winnette wrote 1,119 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 207 | 207 | 31 | $819K |
| Juluca Dolutegravir/Rilpivirine | 87 | 87 | 12 | $299K |
| Dovato Dolutegravir Sodium/Lamivudine | 80 | 80 | Under 11 | $236K |
| Gabapentin Generic | 69 | 69 | Under 11 | $542 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 43 | 43 | Under 11 | $171K |
| Lisinopril Generic | 37 | 39 | Under 11 | $72.11 |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 28 | 28 | Under 11 | $111K |
| Tivicay Dolutegravir Sodium | 27 | 27 | Under 11 | $76K |
| Atorvastatin Calcium Generic | 25 | 27 | Under 11 | $45.35 |
| Amlodipine Besylate Generic | 24 | 24 | Under 11 | $42.47 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 22 | 22 | Under 11 | $104K |
| Duloxetine Hcl Generic | 22 | 22 | Under 11 | $162 |
| Ritonavir Generic | 19 | 21 | Under 11 | $1,380 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 18 | 19 | Under 11 | $241 |
| Lamivudine Hbv Lamivudine | 17 | 17 | Under 11 | $1,983 |
Brand drugs: 591 claims; generic drugs: 528 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gina Winnette $32.24 ($32.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $32.24.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $32.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.